Month: November 2021
-
Drug May Improve Cardiac Function in Hypertrophic Cardiomyopathy
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to a recent clinical trial.
-
Neurobiologists Identify a New Gene Important for Healthy Daily Rhythms
A recent study identified a gene that is critical for daily behavioral rhythms, involved in a molecular pathway by which the core circadian clock controls daily sleep-wake cycles.
-
Inge Joins Lurie Children’s Hospital as Surgeon-in-Chief
Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.
-
New Insights into Cell Polarity
A previously unknown mechanism involving the protein Scribble helps maintain polarity in cells, according to a Northwestern Medicine study.
-
‘Dancing Molecules’ Successfully Repair Severe Spinal Cord Injuries
A new injectable therapy harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries, allowing animal subjects to regain the ability to walk.
-
Students Practice Ophthalmology Surgical Techniques
The student-led Ophthalmology Interest Group recently held a suturing workshop, offering Feinberg students the opportunity to practice surgical techniques on mock organs.
-
Study Shows Epigenetic Modification is Central for Tumor Metastasis
Fatty acid uptake produces an epigenetic modification that is required for cancer metastasis, according to a study published in Nature.
-
Second-year Students Present AOSC Projects
Second-year medical students presented Area of Scholarly Concentration (AOSC) research projects during a virtual session held November 5.
-
Northwestern Medicine Investigators Receive $14 Million Grant to Study Viral Pneumonia
An interdisciplinary team of Northwestern Medicine investigators led by Karen Ridge, PhD, has been awarded a $14 million grant from the National Heart, Lung, and Blood Institute to study the mechanisms that promote lung tissue repair in patients with severe viral pneumonia.
-
New Insights into the Mechanism of ALS
The damaging effects of toxic proteins created in one inherited form of amyotrophic lateral sclerosis (ALS) are mediated by an enzyme called SPOP.
